# China NMPA Drug Inspection - Bozhou Purun Pharmaceutical Co., Ltd. - Ophiopogon japonicus

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/bozhou-purun-pharmaceutical-co-ltd/01da8083-9d9c-43cd-96a9-a9cd5ea39d79/
Source feed: China

> China NMPA drug inspection for Bozhou Purun Pharmaceutical Co., Ltd. published March 25, 2020. Drug: Ophiopogon japonicus. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Drug Quality Bulletin of Guangxi Zhuang Autonomous Region Drug Administration (Issue 1, 2020)
- Company Name: Bozhou Purun Pharmaceutical Co., Ltd.
- Publication Date: 2020-03-25
- Drug Name: Ophiopogon japonicus
- Inspection Finding: [Characteristics]
- Action Taken: The Guangxi Zhuang Autonomous Region Drug Administration has organized relevant drug supervision and management departments to take necessary control measures against drugs that do not meet the standards and to handle them in accordance with the law.

Company: https://www.globalkeysolutions.net/companies/bozhou-purun-pharmaceutical-co-ltd/c29915de-cacb-44cb-9189-491208d13543/